Dissecting Kinase Profiling Data to Predict Activity and Understand Cross-Reactivity of Kinase Inhibitors
- 26 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 52 (4) , 901-912
Abstract
The development of selective and multitargeted kinase inhibitors has received much attention, because cross-reactivity with unintended targets may cause toxic side effects, while it can also give rise to efficacious multitargeted drugs. Here we describe a deconvolution approach to dissecting kinase profiling data in order to gain knowledge about cross-reactivity of inhibitors from large-scale profiling data. This approach not only enables activity predictions of given compounds on a kinome-wide scale, but also allows to extract residue–fragment pairs that are associated with activity. We demonstrate its effectiveness using a large-scale public chemogenomics data set and also apply our proposed model to a recently published bioactivity data set. We further illustrate that the preference of given compounds for kinases of interest is better understood by residue–fragment pairs, which could provide both biological and chemical insights into cross-reactivity.Keywords
This publication has 53 references indexed in Scilit:
- Navigating the kinomeNature Chemical Biology, 2011
- The (un)targeted cancer kinomeNature Chemical Biology, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Strategies for the Design of Selective Protein Kinase InhibitorsMini-Reviews in Medicinal Chemistry, 2008
- An efficient rapid system for profiling the cellular activities of molecular librariesProceedings of the National Academy of Sciences, 2006
- Kinomics: characterizing the therapeutically validated kinase spaceDrug Discovery Today, 2005
- A small molecule–kinase interaction map for clinical kinase inhibitorsNature Biotechnology, 2005
- Kinomics—structural biology and chemogenomics of kinase inhibitors and targetsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002